Leo Pharma finds new medical director at Bayer

German national Jörg Möller takes on the role of executive vice president of Global Research and Development from Jan. 1 and succeeds Kim Kjøller, who will be leaving the company at the turn of the year.
Photo: Leo Pharma / PR
Photo: Leo Pharma / PR
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY NIELSINE NIELSEN

Leo Pharma has decided on the person who will replace Kim Kjøller’s position in the pharmaceutical company, as he will be taking up the position of CEO at Union Therapeutics starting next year.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading